Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

Abstract In this study, we aimed to investigate the feasibility of serum Krebs von den Lungen-6 (KL-6) as a potential biomarker for treatment-related ILD (TR-ILD) in lung cancer. We recruited patients with lung cancer in whom KL-6 was measured to differentiate between pneumonia and ILD (category 1),...

Full description

Bibliographic Details
Main Authors: Hwa Kyung Park, Chang-Seok Yoon, Young-Ok Na, Jae-Kyeong Lee, Hyung-Joo Oh, Ha-Young Park, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon, In-Jae Oh, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Cheol-Kyu Park
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-45170-8

Internet

https://doi.org/10.1038/s41598-023-45170-8

Similar Items